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ABSTRACT 
Background: Over the past decade, the treatment of necrotizing pancreatitis (NP) has 
incorporated greater use of minimally invasive techniques, including percutaneous drainage and 
endoscopic debridement. No study has yet compared outcomes of patients treated with all 
available techniques. We sought to evaluate the evolution of NP treatment at our high volume 
pancreas center. We hypothesized that minimally invasive techniques (medical only, 
percutaneous, and endoscopic) were used more frequently in later years. 
Methods: Treatment strategy of NP patients at a single academic medical center between 2005-
2014 was reviewed.  Definitive management of pancreatic necrosis was categorized as: 1) 
medical treatment only; 2) surgical only; 3) percutaneous (interventional radiology – IR) only; 4) 
endoscopic only; and 5) combination (Surgery+/-IR+/-Endoscopy).     
Results: 526 NP patients included biliary (45%), alcoholic (17%), and idiopathic (20%) 
etiology. Select patients were managed exclusively by medical, IR, or endoscopic treatment; use 
of these therapies remained relatively consistent over time.  A combination of therapies was used 
in about 30% of patients. Over time, the percentage of NP patients managed without operation 
increased from 28% to 41%.  247 (47%) of patients had operation as the only NP treatment; an 
additional 143 (27%) required surgery as part of a multidisciplinary management.  
Conclusion: Select NP patients may be managed exclusively by medical, IR, or endoscopic 
treatment.  Combination treatment is necessary in many NP patients, and surgical treatment 
continues to play an important role in the definitive therapy of necrotizing pancreatitis patients.  
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INTRODUCTION 
Acute pancreatitis is an inflammatory process of the pancreas with a wide range of 
clinical presentations and outcomes. Acute pancreatitis represents a major public health burden 
with over 300,000 hospitalizations/year in the United States, accounting for the second highest 
cost of hospital stays (2.5 billion dollars)1. Most patients will have a mild self-limited course; 
however, up to 20% of patients with AP will ultimately develop necrotizing pancreatitis (NP) 
with an associated 20% mortality rate.  
Major improvements have occurred in the care of NP over the past decades; nevertheless, 
optimal management of this complex heterogeneous disease process remains challenging2,3. 
Patients with infected necrosis and those with symptomatic sterile necrosis require intervention 
of some sort. Traditionally, surgical necrosectomy has been the definitive management of NP, 
although operative debridement is accompanied by significant morbidity (34 to 95%) and 
perioperative mortality (11 to 39%). 2-4 Recently, minimally invasive approaches to pancreatic 
debridement have gained popularity. These minimally invasive approaches include interventional 
radiology (IR)-guided percutaneous drainage and endoscopic drainage. 5-7 
Over the past several years, our experienced pancreatic multidisciplinary group has 
embraced minimally invasive approaches to NP treatment. Therefore, we sought to determine the 
evolution of treatment for NP at our high-volume pancreatic center. We hypothesized that 
minimally invasive approaches were used more commonly in recent years.  
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METHODS 
Patients population 
From 2005 to 2014, all consecutive patients with a diagnosis of NP admitted to Indiana 
University Hospital were included in this study, regardless of the type of treatment provided. 
Patients were identified from a prospectively collected NP database. Electronic medical records 
were queried, and the management strategy was retrospectively manually reviewed. Of the 553 
NP patients treated during the study period, 27 (4.9%) had insufficient data for analysis and were 
excluded from the series. Data were compiled and reported in strict compliance with patient 
confidentiality protocols set forth by Indiana University School of Medicine’s Institutional 
Review Board, which approved the conduct of this study.  
 
Diagnosis of Necrotizing Pancreatitis (NP) 
Acute pancreatitis was defined according to the 2012 revision of the Atlanta 
classification4 as an association of two of the three following features: typical abdominal pain 
(acute onset of a persistent, severe, epigastric pain often radiating to the back), serum lipase or 
amylase activity at least three times greater than the upper limit of normal, and characteristic 
findings of acute pancreatitis on abdominal cross-sectional imaging studies. Necrotizing 
pancreatitis was characterized by inflammation and associated pancreatic parenchymal necrosis 
and/or peripancreatic necrosis, as shown by a lack of pancreatic parenchymal enhancement 
and/or the presence of findings of acute necrotic collection and walled-off necrosis on contrast-
enhanced computed tomography (CT).  
 
Parameters assessed 
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Socio-demographic variables (gender, age at diagnosis) and clinical parameters (etiology, 
presence of infection) were recorded. Data regarding the episode of NP included the date of 
diagnosis (broken down by one-year period), and the type of treatment provided. We defined 
resolution of the NP disease process as the point where no further treatment was required. 
 
Management options 
Definitive management was divided into 6 categories. Patients were considered as 
“medical treatment only” if the only treatment provided was supportive measures (fluid 
resuscitation, intensive care, nutrition support) with or without administration of antibiotics. 
Patients were categorized as “surgical treatment only” if they underwent surgical debridement 
only, regardless of the approach. “Interventional radiology only” consisted of percutaneous 
drainage under CT guidance with placement of 12 to 30Fr catheters. The “endoscopic only” 
approach comprised transluminal endoscopic necrosectomy.  The “combined” group included all 
patients who were treated with two or more approaches.  
 
Statistical analysis 
Data were recorded using Microsoft Excel 2016 (Microsoft, Inc., Redmond, WA, USA) 
and analyzed with IBM SPSS statistics version 21.0® (Armonk, NY: IBM Corp). Descriptive 
statistics were applied to continuous data. Categorical data were expressed as numbers and 
percentages. Categorical data were compared with Fisher’s exact test. Statistical significance was 
defined at p<0.05. 
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RESULTS 
Population characteristics 
From 2005 to 2014, 526 NP patients had complete data available for analysis. Mean age 
at diagnosis of NP was 53 years (range 13-96) with a gender ratio of 1.9 (341 men and 185 
women). The leading etiologies for NP in this series were biliary (n=237, 45%) and alcohol 
(n=89, 17%). In 20% of this population, NP etiology was classified as idiopathic. 
The 424 patients (79%) admitted at an outside institution and secondarily referred to our 
tertiary center were transferred within a median time of 17.2 days from onset of necrotizing 
pancreatitis (range 1 day to 54 days). 
 
Evolving treatment strategy 
Three hundred and ninety patients (74.1%) required surgical debridement over the course 
of their disease, 247 (46.9%) of them as the only treatment, and 143 (27.2%) as part of a 
combined treatment. Necrosectomy was performed via an open approach in 356 patients 
(91.3%), a laparoscopic approach in 25 patients (6.4%), and via a video-assisted retroperitoneal 
approach in 9 patients (2.5%). Overall 193 patients (36.7%) underwent non-surgical therapy with 
interventional radiology or endoscopic drainage. Fifty (9.5%) were treated with those minimally 
invasive approaches alone. Over the study period, 136 patients (25.9%) recuperated with 
supportive therapy, without need for intervention.  
Over time, the percentage of NP patients managed without surgical intervention increased 
from 28% to 41%. Treatment strategies of NP patients are broken down by year in Figure 1. 
Figure 2 shows overall treatment modality.   
Of the 424 patients referred secondarily to our institution, only 19 (4.5%) had some 
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intervention at the outside institution, beside from medical/supportive management. Fifteen 
patients (3.5%) had surgery at the outside hospital, whereas the remaining 4 (1%) had 
percutaneous drainage with interventional radiology. 
In-hospital mortality/year ranges from 8.1% in 2005 to 5.4% in 2014, which is consistent 
with data from the literature that describes an in-hospital mortality between 2 and 39%5,6 . When 
in-hospital mortality for the first 5 years (2005-2009) was compared to the one for the last five 
years (2010-2015), there was a statistically significant decrease from 6.4% to 4.1% (p<0.001). 
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DISCUSSION 
Necrotizing pancreatitis is a heterogeneous disease, and therapy of NP must be individualized to 
specific patient characteristics, including necrosis distribution.  Our multidisciplinary group consists of 
expert endoscopists, interventional radiologists, and pancreatic surgeons.  We utilized multiple 
approaches to NP treatment in this contemporary period, with multiple modality (combined) approaches 
were used more frequently in later years.  Over this time, the number of NP patients treated without 
surgical debridement increased from 28% to 41%.   
Necrosis of the pancreatic parenchyma or peripancreatic parenchyma may resolve on its own, or 
may persist without causing disability.  Few data exist to document the incidence of necrosis resolution 
without treatment; in the current series, approximately 20% of patients recuperated without need for 
intervention, and this number remained relatively consistent over time.   
Minimally invasive approaches to NP treatment were introduced nearly two decades ago; recently 
these techniques (IR directed treatment and endoscopic necrosectomy) have been applied with greater 
frequency.7-9 Over the time period of this study, we found more liberal use of percutaneous IR treatment 
(often as the first treatment in a step-up approach7) as well as the introduction of endoscopic 
necrosectomy.  Endoscopic necrosectomy has been embraced, but applied sparingly in our institutional 
experience, likely reflecting highly select indications, as well as liberal use of surgical transgastric 
debridement.10 Nearly half of our NP patients have a biliary etiology; surgical transgastric necrosectomy 
in these patients permits definitive therapy of contained retrogastric necrosis as well as cholecystectomy 
(with cholangiography) in one procedure under one general anesthetic. 
We have also utilized percutaneous drainage of NP more frequently over the past decade, often as 
a first step in patients who ultimately require multiple modality approach.  While applied more 
commonly, IR drainage proved to be definitive treatment for a smaller percentage (approximately 10%) 
than has been reported elsewhere in the literature9,11,12.  This finding may reflect the complex nature of NP 
patients referred to our tertiary pancreas center. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 9
Surgical debridement has long been the mainstay of treatment for NP.2,3,13 In our practice, 
operative surgical debridement continues to play an important treatment role for NP patients.  We have 
applied minimally invasive surgical techniques to transgastric debridement, laparoscopic transabdominal 
debridement, and retroperitoneal debridement with increasing frequency.  Importantly, these approaches 
are individualized based on specific patient characteristics including necrosis distribution, physiologic 
condition, and failure to progress after other treatment (most commonly percutaneous drainage).14  Over 
this time period we witnessed a significant increase in the number of NP patients successfully without 
surgery; the relatively high number that still require operative debridement (>50%) likely reflects the 
highly complex nature of patients referred to our tertiary center.  These complex clinical scenarios include 
patients who have failed other therapies, as well as those with pancreatic head necrosis and necrosis 
tracking down paracolic gutters and the root of the small bowel mesentery. 
This single institution retrospective series may reflect some selection bias, as patients treated with any 
intervention are easier to track than patients treated by supportive care alone.  Nevertheless, our 
prospectively collected NP database is robust, and does include these medically treated patients.  The 
purpose of this report was simply to evaluate trends in treatment over a time period where minimally 
invasive treatments have been applied more commonly, and we specifically did not focus on patient 
outcomes. Two studies are currently under way at our institution, analyzing specific morphology of 
necrosis and subsequent management, and specifically focusing on long-term outcomes of 
patients with necrotizing pancreatitis. Those studies will help further understand the natural 
history and long-term outcomes of this multi-faceted disease. 
 
In conclusion, necrotizing pancreatitis is a complex and heterogeneous disease.  Treatment must 
be individualized to specific patients based on their disease process and anatomic distribution of necrosis.  
Select patients will recuperate with supportive care alone, percutaneous drainage alone, or endoscopic 
debridement.  Many patients will require more than one modality to effect disease resolution, and 
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operative debridement continues to play an important role in management of these patients.  Evaluation 
by a multidisciplinary treatment team composed of experienced gastroenterologists, surgeons, and 
interventional radiologists is crucial for treatment planning and to achieve optimal patient outcomes. 
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Figure 1. Evolution of management strategy for necrotizing pancreatitis 
Figure 2. Overall treatment modality over the entire study period 
Footnote: 
IR: Interventional radiology 
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Research highlights 
- Optimal management of necrotizing pancreatitis (NP) remains unclear 
- Over the past decades, management of NP has become multidisciplinary 
- Select NP patients may be managed exclusively by medical, IR, or endoscopic treatment.   
- Combination treatment is necessary in many NP patients 
- Surgical treatment continues to play an important role in the definitive therapy of 
necrotizing pancreatitis patients.  
 
